Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kaye

Showing results (651-660 of 853) with videos related to

Pageof 86
Sort By:
Gynecologic Oncology|June 14, 2011
Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancerAndres Poveda, Stanley B Kaye, Robert McCormack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials GroupJ Verweij, J Wanders, A L Nielsen, et al.
British Journal of Cancer|March 1, 1990
A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials CommitteeJ Carmichael, B M Cantwell, K A Mannix, et al.
Ophthalmology|October 1, 2011
Limbal stem cell deficiency and ocular phenotype in ectrodactyly-ectodermal dysplasia-clefting syndrome caused by p63 mutationsEnzo Di Iorio, Stephen B Kaye, Diego Ponzin, et al.
Investigational New Drugs|December 18, 2009
Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trialSimon Pacey, Mark J Ratain, Keith T Flaherty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breastR C Leonard, M A Cornbleet, S B Kaye, et al.
Human Ecology: an Interdisciplinary Journal|March 28, 2020
Ecology of Increasing Diseases: Population Growth and Environmental DegradationD Pimentel, S Cooperstein, H Randell, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2005
A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: a study by the Scottish Gynaecological Cancer Trials Group (SGCTG)N S Reed, C J Poole, R Coleman, et al.
Investigative Ophthalmology & Visual Science|April 7, 2018
Imaging of Corneal Neovascularization: Optical Coherence Tomography Angiography and Fluorescence AngiographyMatthias Brunner, Vito Romano, Bernhard Steger, et al.
Cancer Research|May 15, 1995
Phase I clinical and pharmacokinetic study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762)P A Vasey, D Bissett, M Strolin-Benedetti, et al.
Pageof 86

Showing results (651-660 of 853) with videos related to

Sort By:
Pageof 86
Gynecologic Oncology|June 14, 2011
Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancerAndres Poveda, Stanley B Kaye, Robert McCormack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials GroupJ Verweij, J Wanders, A L Nielsen, et al.
British Journal of Cancer|March 1, 1990
A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials CommitteeJ Carmichael, B M Cantwell, K A Mannix, et al.
Ophthalmology|October 1, 2011
Limbal stem cell deficiency and ocular phenotype in ectrodactyly-ectodermal dysplasia-clefting syndrome caused by p63 mutationsEnzo Di Iorio, Stephen B Kaye, Diego Ponzin, et al.
Investigational New Drugs|December 18, 2009
Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trialSimon Pacey, Mark J Ratain, Keith T Flaherty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breastR C Leonard, M A Cornbleet, S B Kaye, et al.
Human Ecology: an Interdisciplinary Journal|March 28, 2020
Ecology of Increasing Diseases: Population Growth and Environmental DegradationD Pimentel, S Cooperstein, H Randell, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2005
A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: a study by the Scottish Gynaecological Cancer Trials Group (SGCTG)N S Reed, C J Poole, R Coleman, et al.
Investigative Ophthalmology & Visual Science|April 7, 2018
Imaging of Corneal Neovascularization: Optical Coherence Tomography Angiography and Fluorescence AngiographyMatthias Brunner, Vito Romano, Bernhard Steger, et al.
Cancer Research|May 15, 1995
Phase I clinical and pharmacokinetic study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762)P A Vasey, D Bissett, M Strolin-Benedetti, et al.
Pageof 86